FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stefan Balabanov

Research Profile

Anatomy

Chemicals & Drugs

Physiology

Procedures

Disorders

Living Beings

Mouse

Occupations

Proteomics

Co-author Network

Publications

TOP 3
T Martens; J Matschke; C Müller; S Riethdorf; M Westphal; Stefan Balabanov; Oliver Heese
Skeletal spread of an anaplastic astrocytoma (WHO grade III) and preservation of histopathological properties within metastases.
Stefan Balabanov; Christine Barett; Carsten Bokemeyer; Melanie Braig; Tim H Brümmendorf; Gunhild Keller; Heike Pospisil; Christian Scharf; Simone Venz; Reinhard Walther; Thomas Wilhelm; Andreas Schuppert
Combination of a proteomics approach and reengineering of meso scale network models for prediction of mode-of-action for tyrosine kinase inhibitors.
Stefan Balabanov; Mhairi Copland; Caroline A Evans; Francesca Pellicano; Michael J Walker; Anthony D Whetton; Sheela A Abraham; Tessa L Holyoake
Quantitative proteomics analysis of BMS-214662 effects on CD34 positive cells from chronic myeloid leukaemia patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stefan Balabanov (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: T Martens; J Matschke; C Müller; S Riethdorf; M Westphal; Stefan Balabanov; Oliver Heese
Skeletal spread of an anaplastic astrocytoma (WHO grade III) and preservation of histopathological properties within metastases.
Clinical neurology and neurosurgery 2013;115(3):323-8.
2013: Stefan Balabanov; Christine Barett; Carsten Bokemeyer; Melanie Braig; Tim H Brümmendorf; Gunhild Keller; Heike Pospisil; Christian Scharf; Simone Venz; Reinhard Walther; Thomas Wilhelm; Andreas Schuppert
Combination of a proteomics approach and reengineering of meso scale network models for prediction of mode-of-action for tyrosine kinase inhibitors.
PloS one 2013;8(1):e53668.
2013: Stefan Balabanov; Mhairi Copland; Caroline A Evans; Francesca Pellicano; Michael J Walker; Anthony D Whetton; Sheela A Abraham; Tessa L Holyoake
Quantitative proteomics analysis of BMS-214662 effects on CD34 positive cells from chronic myeloid leukaemia patients.
Proteomics 2013;13(1):153-68.
2012: Patrick Ziegler; Susanne Ziegler; Stefan Balabanov; Melanie Braig; Tuhama Chahoud; Joachim Hauber; Adrian Kolodzik; Chris Meier; Nora Pällman; Jens Panse; Matthias Rarey; Marcus Schröder; Valeska Wiehle; Thomas Wilhelm; Tim H Brümmendorf
Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemias.
Investigational new drugs 2012;30(6):2274-83.
2012: B Nitzsche; Mark Schrader; F Zengerling; Stefan Balabanov; C Gloesenkamp; B Hoffmann; Friedemann Honecker; Michael Höpfner
Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer.
British journal of cancer 2012;107(11):1853-63.
2012: Henning Sievert; Simone Venz; Reinhard Walther; Carsten Bokemeyer; Melanie Braig; Tim H Brümmendorf; Vishnu M Dhople; Kent E Duncan; Joachim Hauber; Claus-Henning Nagel; Nora Pällmann; Oscar Platas-Barradas; Ralf Pörtner; Michael Preukschas; Martin Schaletzky; Stefan Balabanov
Protein-protein-interaction network organization of the hypusine modification system.
Molecular & cellular proteomics : MCP 2012;11(11):1289-305.
2012: Catherine Meyer-Schwesinger; Marlies Sachs; Friedrich Thaiss; Kazem Arefi; Stefan Balabanov; Jan U Becker; Silke Dehde; Stefan Gatzemeier; Sabrina Mathey; Tobias N Meyer
Rho-kinase inhibition prevents proteinuria in immune-complex-mediated antipodocyte nephritis.
American journal of physiology. Renal physiology 2012;303(7):F1015-25.
2012: Patrick Ziegler; Jamil Akkad; Stefan Balabanov; Ute Brassat; Uwe M Martens; Jens Panse; Hubert Schrezenmeier; Klaus Schwarz; Lucia Vankann; Stefan Wilop; Tim H Brümmendorf
Telomere elongation and clinical response to androgen treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutation.
Annals of hematology 2012;91(7):1115-20.
2012: Ramesh Ummanni; Simone Venz; Reinhard Walther; Christine Barett; Frederico Barreto; Carsten Bokemeyer; Jan Christoph Brase; Tim H Brümmendorf; Ulrike Korf; Ruprecht Kuner; Heiko A Mannsperger; Guido Sauter; Christian Scharf; Thorsten Schlomm; Holger Sültmann; Stefan Balabanov
Peroxiredoxins 3 and 4 are overexpressed in prostate cancer tissue and affect the proliferation of prostate cancer cells in vitro.
Journal of proteome research 2012;11(4):2452-66.
2012: Sergey A Dyshlovoy; Sergey N Fedorov; Manuela Gesell Salazar; Joachim Hauber; Stefan Balabanov; Carsten Bokemeyer; Christine Jacobsen; Marcel Krepstakies; Ina Naeth; Michael Preukschas; Poornima Priyadarshini; Christian Scharf; Larisa K Shubina; Henning Sievert; Valentin A Stonik; Simone Venz; Reinhard Walther; Friedemann Honecker
Proteomic profiling of germ cell cancer cells treated with aaptamine, a marine alkaloid with antiproliferative activity.
Journal of proteome research 2012;11(4):2316-30.
2012: Michael Preukschas; Alexander Schulte; Henning Sievert; Kristoffer Weber; Carsten Bokemeyer; Melanie Braig; Christian Hagel; Joachim Hauber; Katrin Lamszus; Nora Pällmann; Stefan Balabanov
Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.
PloS one 2012;7(8):e43468.
2011: Catherine Meyer-Schwesinger; Marcela Pekna; Friedrich Thaiss; Simone Venz; Kazem Arefi; Stefan Balabanov; Jan U Becker; Silke Dehde; Karlhans Endlich; J Engelbert Gessner; Philipp Klug; Sabrina Mathey; Tobias N Meyer
Nephrotic syndrome and subepithelial deposits in a mouse model of immune-mediated anti-podocyte glomerulonephritis.
Journal of immunology (Baltimore, Md. : 1950) 2011;187(6):3218-29.
2011: Catherine Meyer-Schwesinger; Tobias N Meyer; Henning Sievert; Elion Hoxha; Marlies Sachs; Eva-Maria Klupp; Silvia Münster; Stefan Balabanov; Lucie Carrier; Udo Helmchen; Friedrich Thaiss; Rolf A K Stahl
Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy.
The American journal of pathology 2011;178(5):2044-57.
2011: Sarah Minner; Corinna Wittmer; Markus Graefen; Georg Salomon; Thomas Steuber; Alexander Haese; Hartwig Huland; Carsten Bokemeyer; Emre F Yekebas; Judith Dierlamm; Stefan Balabanov; Ergin Kilic; Waldemar Wilczak; Ronald Simon; Guido Sauter; Thorsten Schlomm
High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.
The Prostate 2011;71(3):281-8.
2011: Ramesh Ummanni; Christine Barett; Carsten Bokemeyer; Melanie Braig; Tim H Brümmendorf; Edgar Jost; Frithjof Lohmann; Catherine Meyer-Schwesinger; Frederike Mundt; Guido Sauter; Thorsten Schlomm; Tina Senff; Holger Sültmann; Stefan Balabanov
Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation.
Molecular cancer 2011;10():129.
2011: Stefan Balabanov; Artur Gontarewicz; Gunhild Keller; Laura Raddrizzani; Melanie Braig; Roberta Bosotti; Jürgen Moll; Edgar Jost; Christine Barett; Imke Rohe; Carsten Bokemeyer; Tessa L Holyoake; Tim H Brümmendorf
Abcg2 overexpression represents a novel mechanism for acquired resistance to the multi-kinase inhibitor Danusertib in BCR-ABL-positive cells in vitro.
PloS one 2011;6(4):e19164.
2011: Ramesh Ummanni; Frederike Mundt; Heike Pospisil; Simone Venz; Christian Scharf; Christine Barett; Maria Fälth; Jens Köllermann; Reinhard Walther; Thorsten Schlomm; Guido Sauter; Carsten Bokemeyer; Holger Sültmann; A Schuppert; Tim H Brümmendorf; Stefan Balabanov
Identification of clinically relevant protein targets in prostate cancer with 2D-DIGE coupled mass spectrometry and systems biology network platform.
PloS one 2011;6(2):e16833.
2011: Ute Brassat; Stefan Balabanov; Daniel Bali; Judith Dierlamm; Melanie Braig; Ulrike Hartmann; Hüseyin Sirma; Cagatay Günes; Henning Wege; Boris Fehse; Artur Gontarewicz; Ekkehard Dikomey; Kerstin Borgmann; Tim H Brümmendorf
Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells.
Experimental hematology 2011;39(1):66-76.e1-2.
2010: Mascha Binder; Barbara Léchenne; Ramesh Ummanni; Christan Scharf; Stefan Balabanov; Maria Trusch; Hartmut Schlüter; Ingke Braren; Edzard Spillner; Martin Trepel
Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells.
PloS one 2010;5(12):e15992.
2009: Daniel Benten; Gunhild Keller; Alexander Quaas; Jorg Schrader; Artur Gontarewicz; Stefan Balabanov; Melanie Braig; Henning Wege; Jurgen Moll; Ansgar W Lohse; Tim H Brummendorf
Aurora kinase inhibitor PHA-739358 suppresses growth of hepatocellular carcinoma in vitro and in a xenograft mouse model.
Neoplasia (New York, N.Y.) 2009;11(9):934-44.
2008: Stephanie Glaesener; Friedemann Honecker; Imke M Veltman; Ad J M Gillis; Tina Rohlfing; Thomas Streichert; Benjamin Otto; Tim H Brummendorf; Leendert H J Looijenga; Carsten Bokemeyer; Stefan Balabanov
Comparative proteome, transcriptome, and genome analysis of a gonadal and an extragonadal germ cell tumor cell line.
Journal of proteome research 2008;7(9):3890-9.
2008: Artur Gontarewicz; Stefan Balabanov; Gunhild Keller; Riccardo Colombo; Alessio Graziano; Enrico Pesenti; Daniel Benten; Carsten Bokemeyer; Walter Fiedler; Jurgen Moll; Tim H Brümmendorf
Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I.
Blood 2008;111(8):4355-64.
2007: Sandra Mueller; Ulrike Hartmann; Frank Mayer; Stefan Balabanov; Jörg Thomas Hartmann; Tim H Brummendorf; Carsten Bokemeyer
Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumors.
Investigational new drugs 2007;25(6):519-24.
2007: Mark W Drummond; Stefan Balabanov; Tessa L Holyoake; Tim H Brummendorf
Concise review: Telomere biology in normal and leukemic hematopoietic stem cells.
Stem cells (Dayton, Ohio) 2007;25(8):1853-61.
2007: Stefan Balabanov; Artur Gontarewicz; Patrick Ziegler; Ulrike Hartmann; Winfried Kammer; Mhairi Copland; Ute Brassat; Martin Priemer; Ilona Hauber; Thomas Wilhelm; Gerold Schwarz; Lothar Kanz; Carsten Bokemeyer; Joachim Hauber; Tessa L Holyoake; Alfred Nordheim; Tim H Brümmendorf
Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach.
Blood 2007;109(4):1701-11.
2007: F Beier; Stefan Balabanov; CC Amberger; Ulrike Hartmann; K Manger; Klaus Dietz; Ina Kötter; Tim H Brummendorf
Telomere length analysis in monocytes and lymphocytes from patients with systemic lupus erythematosus using multi-color flow-FISH.
Lupus 2007;16(12):955-62.
2006: Tim H Brümmendorf; Stefan Balabanov
Telomere length dynamics in normal hematopoiesis and in disease states characterized by increased stem cell turnover.
Leukemia 2006;20(10):1706-16.
2006: Uwe Zimmermann; Heike Junker; Fabian Krämer; Stefan Balabanov; Britta Kleist; Winfried Kammer; Alfred Nordheim; Reinhard Walther
Comparative proteomic analysis of neoplastic and non-neoplastic germ cell tissue.
Biological chemistry 2006;387(4):437-40.
2005: Silke Appel; Stefan Balabanov; Tim H Brümmendorf; Peter Brossart
Effects of imatinib on normal hematopoiesis and immune activation.
Stem cells (Dayton, Ohio) 2005;23(8):1082-8.
2005: Kerol Bartolović; Stefan Balabanov; Birgit Berner; Hans-Jörg Bühring; Martina Komor; Sven Becker; Dieter Hoelzer; Lothar Kanz; Wolf-Karsten Hofmann; Tim H Brümmendorf
Clonal heterogeneity in growth kinetics of CD34+CD38- human cord blood cells in vitro is correlated with gene expression pattern and telomere length.
Stem cells (Dayton, Ohio) 2005;23(7):946-57.
2005: Stefan Balabanov; Kerol Bartolovic; Martina Komor; Lothar Kanz; Wolf-Karsten Hofmann; Tim H Brümmendorf
Gene expression profiling of normal hematopoietic progenitor cells under treatment with imatinib in vitro.
Leukemia 2005;19(8):1483-5.
2005: Fabian Beier; Stefan Balabanov; Tom Buckley; Klaus Dietz; Ulrike Hartmann; Markus T Rojewski; Lothar Kanz; Hubert Schrezenmeier; Tim H Brümmendorf
Accelerated telomere shortening in glycosylphosphatidylinositol (GPI)-negative compared with GPI-positive granulocytes from patients with paroxysmal nocturnal hemoglobinuria (PNH) detected by proaerolysin flow-FISH.
Blood 2005;106(2):531-3.
2005: Stefan Balabanov; Silke Appel; Lothar Kanz; Peter Brossart; Tim H Brümmendorf
Effect of tyrosine kinase inhibition using imatinib on normal lymphohematopoietic cells.
Annals of the New York Academy of Sciences 2005;1044():168-77.
2005: Ulrike Hartmann; Stefan Balabanov; Patrick Ziegler; Jörg Fellenberg; Heiko van der Kuip; Justus Duyster; Hans-Peter Lipp; Carsten Bokemeyer; Lothar Kanz; Tim H Brümmendorf
Telomere length and telomerase activity in the BCR-ABL-transformed murine Pro-B cell line BaF3 is unaffected by treatment with imatinib.
Experimental hematology 2005;33(5):542-9.
2005: Ulrike Hartmann; Tim H Brümmendorf; Stefan Balabanov; Christian Thiede; Thomas Illme; Markus Schaich
Telomere length and hTERT expression in patients with acute myeloid leukemia correlates with chromosomal abnormalities.
Haematologica 2005;90(3):307-16.
2004: Reinhard Walther; Stefan Balabanov; Heike Junker; Christian Scharf; Uwe Zimmermann
Proteome analysis of renal cell carcinoma to develop new strategies in diagnosis and therapy.
International journal of clinical pharmacology and therapeutics 2004;42(11):635-6.
2004: Uwe Zimmermann; Stefan Balabanov; Jürgen Giebel; Steffen Teller; Heike Junker; Dieter Schmoll; Chris Protzel; Christian Scharf; Britta Kleist; Reinhard Walther
Increased expression and altered location of annexin IV in renal clear cell carcinoma: a possible role in tumour dissemination.
Cancer letters 2004;209(1):111-8.
2004: Kerstin Dallmann; Heike Junker; Stefan Balabanov; Uwe Zimmermann; Jürgen Giebel; Reinhard Walther
Human agmatinase is diminished in the clear cell type of renal cell carcinoma.
International journal of cancer. Journal international du cancer 2004;108(3):342-7.
2004: Kerol Bartolovic; Stefan Balabanov; Ulrike Hartmann; Martina Komor; Andreas M Boehmler; Hans-Jörg Bühring; Robert Möhle; Dieter Hoelzer; Lothar Kanz; Wolf-Karsten Hofmann; Tim H Brümmendorf
Inhibitory effect of imatinib on normal progenitor cells in vitro.
Blood 2004;103(2):523-9.
2003: Stefan Scheding; Inci Ersöz; Ulrike Hartmann; Kerol Bartolvic; Stefan Balabanov; Abdulgabar Salama; Lothar Kanz; Tim H Brümmendorf
Peripheral blood cell telomere length measurements indicate that hematopoietic stem cell turnover is not significantly increased in whole blood and apheresis PLT donors.
Transfusion 2003;43(8):1089-95.
2003: Tim H Brummendorf; Inci Ersoz; Ulrike Hartmann; Stefan Balabanov; Holger Wolke; Peter Paschka; Tanja Lahaye; Birgit Berner; Kerol Bartolovic; Sebastian Kreil; Ute Berger; Harald Gschaidmeier; Carsten Bokemeyer; Rüdiger Hehlmann; Klaus Dietz; Peter M Lansdorp; Lothar Kanz; Andreas Hochhaus
Normalization of previously shortened telomere length under treatment with imatinib argues against a preexisting telomere length deficit in normal hematopoietic stem cells from patients with chronic myeloid leukemia.
Annals of the New York Academy of Sciences 2003;996():26-38.
2003: Tim H Brümmendorf; Inci Ersöz; Ulrike Hartmann; Kerol Bartolovic; Stefan Balabanov; Alexandra Wahl; Peter Paschka; Sebastian Kreil; Tanja Lahaye; Ute Berger; Harald Gschaidmeier; Carsten Bokemeyer; Rüdiger Hehlmann; Klaus Dietz; Peter M Lansdorp; Lothar Kanz; Andreas Hochhaus
Telomere length in peripheral blood granulocytes reflects response to treatment with imatinib in patients with chronic myeloid leukemia.
Blood 2003;101(1):375-6.
2001: Stefan Balabanov; Uwe Zimmermann; Chris Protzel; Christian Scharf; Klaus-Jürgen Klebingat; Reinhard Walther
Tumour-related enzyme alterations in the clear cell type of human renal cell carcinoma identified by two-dimensional gel electrophoresis.
European journal of biochemistry / FEBS 2001;268(22):5977-80.
2001: Dieter Schmoll; Stefan Balabanov; D Schwarck; Ann Burchell; Britta Kleist; Uwe Zimmermann; Reinhard Walther
Differential expression of the subunits of the glucose-6-phosphatase system in the clear cell type of human renal cell carcinoma - no evidence for an overexpression of protein kinase B.
Cancer letters 2001;167(1):85-90.